BÂLE, Suisse, 26 juillet 2023 /PRNewswire/ — CordenPharma, organisation de fabrication et de développement sous contrat (CDMO) pharmaceutique de premier plan, a créé un nouveau conseil consultatif technologique et scientifique (TSAB) composé de huit experts de classe mondiale issus du…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.